Open access
Jul 2026
Impact of RASopathy subtype on the early disease course of RASopathy-associated hypertrophic cardiomyopathy: clinical outcomes and genetic insights.
It is demonstrated that RASopathy subtype may influence hypertrophic cardiomyopathy (HCM) progression and clinical outcomes in pediatric patients and echocardiographic parameters (IVSd and LVPWd), and RASopathy subtype may serve as prognostic indicators in pediatric RAS-HCM patients.
J. L. López-Guillén, A. Carcavilla, Jesús Díez-Sebastián et al.
· Pediatric Research · 0 citations